Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Clinics in Chest Medicine
|
May 24, 2021
Management of Idiopathic Pulmonary Fibrosis
Margaret L Salisbury, Marlies S Wijsenbeek
Chest
|
February 20, 2021
Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations
Carla R Copeland, Bridget F Collins, Margaret L Salisbury
Current Opinion in Pulmonary Medicine
|
June 27, 2017
Microbiome in interstitial lung disease: from pathogenesis to treatment target
Margaret L Salisbury, MeiLan K Han, Robert P Dickson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis
Xiang Huang, Pingsheng Wu, Adam R Guttentag, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 13, 2024
Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study
Margaret L Salisbury, Cheryl Markin, Tisra Fadely, et al.
Respiratory Medicine
|
September 1, 2016
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling
Margaret L Salisbury, Meng Xia, Susan Murray, et al.
BMJ Open Respiratory Research
|
May 16, 2024
Scoping review of exposure questionnaires and surveys in interstitial lung disease
Hayley Barnes, Seham Elmrayed, Christopher Michael Barber, et al.
Annals of the American Thoracic Society
|
June 24, 2020
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
Margaret L Salisbury, Craig S Conoscenti, Daniel A Culver, et al.
Chest
|
October 2, 2015
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline
Margaret L Salisbury, Meng Xia, Yueren Zhou, et al.
Lung
|
September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy
Julia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Clinics in Chest Medicine
|
May 24, 2021
Management of Idiopathic Pulmonary Fibrosis
Margaret L Salisbury, Marlies S Wijsenbeek
Chest
|
February 20, 2021
Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations
Carla R Copeland, Bridget F Collins, Margaret L Salisbury
Current Opinion in Pulmonary Medicine
|
June 27, 2017
Microbiome in interstitial lung disease: from pathogenesis to treatment target
Margaret L Salisbury, MeiLan K Han, Robert P Dickson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis
Xiang Huang, Pingsheng Wu, Adam R Guttentag, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 13, 2024
Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study
Margaret L Salisbury, Cheryl Markin, Tisra Fadely, et al.
Respiratory Medicine
|
September 1, 2016
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling
Margaret L Salisbury, Meng Xia, Susan Murray, et al.
BMJ Open Respiratory Research
|
May 16, 2024
Scoping review of exposure questionnaires and surveys in interstitial lung disease
Hayley Barnes, Seham Elmrayed, Christopher Michael Barber, et al.
Annals of the American Thoracic Society
|
June 24, 2020
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
Margaret L Salisbury, Craig S Conoscenti, Daniel A Culver, et al.
Chest
|
October 2, 2015
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline
Margaret L Salisbury, Meng Xia, Yueren Zhou, et al.
Lung
|
September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy
Julia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
Page
of 3